Drugplain

Staphysagria 30 [hp_X]/30[hp_X]

DELPHINIUM STAPHISAGRIA SEED · PELLET · Boiron

No Recall History
Plain English

Staphysagria is a pellet containing delphinium staphisagria seed at 30 [hp_X]/30[hp_X], taken oral. Manufactured by Boiron.

Key Facts

Brand Name
Staphysagria
Generic Name
DELPHINIUM STAPHISAGRIA SEED
NDC Code (Product)
0220-4885
Manufacturer
Boiron
Strength
30 [hp_X]/30[hp_X]
Dosage Form
PELLET
Route
ORAL
Marketing Status
Marketing Start
03/03/1983

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

bunion operation1 reports
foot deformity1 reports
sinus disorder1 reports
synovial cyst1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

USE: Condition listed above or as directed by a physician.

Dosage & Administration

DIRECTIONS: (adults/children) Dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a physician.

Warnings

WARNINGS: Stop use and ask a physician if symptoms persist for more than 3 days or worsen.

Frequently Asked Questions

What is Staphysagria used for?

Staphysagria contains DELPHINIUM STAPHISAGRIA SEED. It is a pellet taken oral. Consult your doctor for specific uses.

Is Staphysagria a controlled substance?

Staphysagria is not classified as a controlled substance by the DEA.

What is the generic name for Staphysagria?

The generic name for Staphysagria is DELPHINIUM STAPHISAGRIA SEED. There are no other listed brand versions of DELPHINIUM STAPHISAGRIA SEED.

What is the NDC code for Staphysagria 30 [hp_X]/30[hp_X]?

The NDC (National Drug Code) for Staphysagria 30 [hp_X]/30[hp_X] is 0220-4885, listed by Boiron.

Product NDC

0220-4885

Package NDC

0220-4885-41

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)